Short Interest in INVO Fertility, Inc (NASDAQ:IVF) Drops By 30.1%

INVO Fertility, Inc (NASDAQ:IVF) saw a large drop in short interest in December. As of December 31st, there was short interest totaling 66,048 shares, a drop of 30.1% from the December 15th total of 94,554 shares. Based on an average trading volume of 127,052 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.8% of the shares of the stock are short sold. Approximately 2.8% of the shares of the stock are short sold. Based on an average trading volume of 127,052 shares, the days-to-cover ratio is currently 0.5 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of INVO Fertility in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

INVO Fertility Stock Performance

Shares of NASDAQ:IVF traded down $0.00 during mid-day trading on Friday, reaching $0.81. 46,289,934 shares of the company’s stock were exchanged, compared to its average volume of 127,060. INVO Fertility has a twelve month low of $0.71 and a twelve month high of $148.23. The firm has a market capitalization of $1.94 million, a price-to-earnings ratio of 0.00 and a beta of 2.60. The business’s fifty day moving average price is $1.74 and its 200-day moving average price is $7.50.

Institutional Investors Weigh In On INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Citadel Advisors LLC acquired a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned approximately 1.19% of INVO Fertility at the end of the most recent reporting period. Institutional investors own 12.02% of the company’s stock.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.